Robeco Institutional Asset Management B.V. - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q3 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.

Quarter-by-quarter ownership
Robeco Institutional Asset Management B.V. ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$362,978
-53.7%
4,052
-56.0%
0.00%
-50.0%
Q2 2023$783,288
+2.9%
9,2000.0%0.00%0.0%
Q1 2023$761,302
+184.7%
9,200
+170.6%
0.00%
+100.0%
Q4 2022$267,410
-98.7%
3,400
-98.3%
0.00%
-98.9%
Q4 2018$20,151,000
-13.9%
203,733
-0.3%
0.09%
-3.2%
Q3 2018$23,402,000
+28.1%
204,261
+0.2%
0.09%
+12.0%
Q2 2018$18,272,000203,7610.08%
Other shareholders
HAEMONETICS CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Iron Triangle Partners LP 330,000$36,633,0004.66%
BEACONLIGHT CAPITAL, LLC 156,395$17,361,0002.80%
Bridge City Capital, LLC 48,011$5,330,0001.77%
Summit Creek Advisors LLC 121,362$13,472,0001.61%
Sivik Global Healthcare LLC 25,000$2,775,0001.01%
ANCHOR CAPITAL ADVISORS LLC 412,218$45,760,0000.97%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 69,655$7,732,0000.90%
Orbimed Advisors 852,000$94,581,0000.88%
LONDON CO OF VIRGINIA 1,057,738$117,420,0000.67%
WEXFORD CAPITAL LP 40,138$4,456,0000.66%
View complete list of HAEMONETICS CORP shareholders